| Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors J George, V Walter, M Peifer, LB Alexandrov, D Seidel, F Leenders, ... Nature communications 9 (1), 1048, 2018 | 310 | 2018 |
| Identification of circulating tumor DNA for the early detection of small-cell lung cancer L Fernandez-Cuesta, S Perdomo, PH Avogbe, N Leblay, TM Delhomme, ... EBioMedicine 10, 117-123, 2016 | 206 | 2016 |
| Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids N Alcala, N Leblay, AAG Gabriel, L Mangiante, D Hervás, T Giffon, ... Nature communications 10 (1), 3407, 2019 | 161 | 2019 |
| KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control F Le Calvez-Kelm, M Foll, MB Wozniak, TM Delhomme, G Durand, ... Oncotarget 7 (48), 78827, 2016 | 82 | 2016 |
| Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study MI Hosen, M Sheikh, M Zvereva, G Scelo, N Forey, G Durand, C Voegele, ... EBioMedicine 53, 2020 | 64 | 2020 |
| Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer PH Avogbe, A Manel, E Vian, G Durand, N Forey, C Voegele, M Zvereva, ... EBioMedicine 44, 431-438, 2019 | 59 | 2019 |
| Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity L Mangiante, N Alcala, A Sexton-Oates, A Di Genova, A Gonzalez-Perez, ... Nature Genetics 55 (4), 607-618, 2023 | 36 | 2023 |
| Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer MI Hosen, N Forey, G Durand, C Voegele, S Bilici, PH Avogbe, ... Cancers 12 (12), 3541, 2020 | 32 | 2020 |
| Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA M Zvereva, G Roberti, G Durand, C Voegele, MD Nguyen, TM Delhomme, ... EBioMedicine 55, 2020 | 21 | 2020 |
| Needlestack: An ultra-sensitive variant caller for multi-sample next generation sequencing data TM Delhomme, PH Avogbe, AAG Gabriel, N Alcala, N Leblay, C Voegele, ... NAR Genomics and Bioinformatics 2 (2), lqaa021, 2020 | 8 | 2020 |
| TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation D Nasrollahzadeh, G Roshandel, TM Delhomme, PH Avogbe, M Foll, ... International Journal of Molecular Sciences 22 (11), 5627, 2021 | 7 | 2021 |
| Disentangling heterogeneity of Malignant Pleural Mesothelioma through deep integrative omics analyses L Mangiante, N Alcala, A Di Genova, A Sexton-Oates, A Gonzalez-Perez, ... BioRxiv, 2021.09. 27.461908, 2021 | 5 | 2021 |
| The PI3K/mTOR pathway is targeted by rare germline variants in patients with both melanoma and renal cell carcinoma JN Hubert, V Suybeng, M Vallee, TM Delhomme, E Maubec, A Boland, ... Cancers 13 (9), 2243, 2021 | 4 | 2021 |
| KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control. Oncotarget. 2016; 7 (48): 78827–40 F Le Calvez-Kelm, M Foll, MB Wozniak, TM Delhomme, G Durand, ... | 4 | |
| Identification of circulating tumor DNA for the early detection of small-cell lung cancer. EBioMedicine 10: 117–123 L Fernandez-Cuesta, S Perdomo, PH Avogbe, N Leblay, TM Delhomme, ... | 3 | 2016 |
| Proton and alpha radiation-induced mutational profiles in human cells TM Delhomme, M Munteanu, M Buonanno, V Grilj, J Biayna, F Supek Scientific Reports 13 (1), 9791, 2023 | 2 | 2023 |
| Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma N Leblay, N Alcala, DH Marin, TM Delhomme, T Giffon, A Ghantous, ... Cancer Research 78 (13_Supplement), 5358-5358, 2018 | 1 | 2018 |
| Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer R Boidot, MGB Blum, MP Wissler, C Gottin, J Ruzicka, S Chevrier, ... European Journal of Cancer 202, 113978, 2024 | | 2024 |
| Multi-Omic Characterization and Evolution of Neuroendocrine Neoplasm Organoids N Alcala, T Dayton, L Mangiante, T Delhomme, S Tabone-Egling, ... NEUROENDOCRINOLOGY 110, 34-34, 2020 | | 2020 |
| Circulating cell-free DNA in archived low-quality volume serum samples: rate of concordance with mutation in tumour D Nasrollahzadeh, B Abedi-Ardekani, T Delhomme, PH Avogbe, M Foll, ... VIRCHOWS ARCHIV 475, S61-S61, 2019 | | 2019 |
